Table 2 Implication for CKD staging when an enzymatic or a standardized serumcreatinine is used
| Â | Â | MDRD enzymatic p10/ p90 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | <30 ml/min/1.73 m2 | 30-45 ml/min/1.73 m2 | 45-60 ml/min/1.73 m2 | 60-90 ml/min/1.73 m2 | >90 ml/min/1.73 m2 | Total | |||||
| Â | Â | p10 | p90 | p10 | p90 | p10 | p90 | p10 | p90 | p10 | p90 | Â |
MDRD standardized | <30 ml/min/1.73 m2 | 2483 (97.6%) | 2543 (100%) | 60 (2.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2543 |
| Â | 30-45 ml/min/1.73 m2 | 0 (0%) | 141 (3.6%) | 3299 (84.4%) | 3768 (96.4%) | 610 (15.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 3909 |
| Â | 45-60 ml/min/1.73 m2 | 0 (0%) | 0 (0%) | 0 (0%) | 338 (4.1%) | 5740 (69.9%) | 7878 (95.9%) | 2476 (30.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 8216 |
| Â | 60-90 ml/min/1.73 m2 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 845 (2.1%) | 28308 (71.1%) | 38976 (97.9%) | 11513 (28.9%) | 0 (%) | 39821 |
| Â | >90 ml/min/1.73 m2 | 5 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1502 (5.4%) | 27930 (100%) | 26433 (94.6%) | 27935 |
| Â | Â | 2488 | 2684 | 3359 | 4106 | 6350 | 8723 | 30784 | 40478 | 39443 | 26433 | 82424 |